{
  "meta": {
    "trial_1_label": "placebo",
    "trial_1_text": "Pirfenidone  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Placebo Placebo: 40 participants will take placebo in the form of a capsule. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Pirfenidone. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Pirfenidone  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry.",
    "trial_2_label": "pirfenidone",
    "trial_2_text": "Pirfenidone  Covid19 Sequelae of; Infection Cognitive Symptom  Effect of Niagen on NAD+ and Cognitive Functioning  Pirfenidone Supplement: 60 participants will take Pirfenidone 2000mg in the form of capsules daily. [COUNTERFACTUAL ANALYSIS] Original drug (Niagen) replaced with Pirfenidone. Original summary: The study will assess whether Niagen, a safe dietary supplement, improves recovery of COVID-19 related symptoms in individuals who were infected at least 2 months prior to study entry (\"Long-COVID\" \"Long-haulers\"). 60% of participants will receive Niagen and 40% will receive PBO. Outcomes will consist of standardized cognitive, neuropsychiatric, physical, functional and biomarker assessments. Replacement drug: Pirfenidone  Inclusion Criteria:\n\n* History of SARS-CoV-2 PCR+ at least 2 months prior to study entry;\n* SARS-CoV-2 negative (PCR) at study entry;\n* Persistent cognitive difficulties (esp. \"brain fog\") that began around the time of the acute COVID-19;\n* At least two neurological and/or physical symptoms that started with COVID-19 infection and are ongoing at study entry, including fatigue, weakness, headache, loss of smell, tingling/numbness, shortness of breath, loss of appetite, palpitations/tachycardia, hair loss, musculoskeletal and/or chest pain;\n* Willing and able to consent, complete all assessment and study procedures;\n* Not pregnant or lactating.\n\nExclusion Criteria:\n\n* Any specific central nervous system disease history (e.g. major clinical stroke, brain tumor, normal pressure hydrocephalus, etc);\n* Clinically significant unstable medical condition that could affect safety or compliance with the study;\n* Was intubated due to COVID-19;\n* Major active or chronic unstable psychiatric illness (e.g. depression, bipolar disorder, obsessive compulsive disorder, schizophrenia) within the previous year;\n* History of alcohol or other substance abuse or dependence within the past two years;\n* Any significant systemic illness or medical condition that could affect safety or compliance with study;\n* Current use of medications with psychoactive properties that may be deleteriously affecting cognition;\n* Any known hypersensitivity to nicotinamide riboside, or its principal metabolite, nicotinamide mononucleotide;\n* Use of other investigational agents or interventions one month prior to entry and for the duration of the trial;\n* If participating in the optional magnetic resonance imaging (MRI) sub-study: Any contraindication to undergo MRI;\n* Pregnant women or women who are planning to become pregnant within 7 months from study entry."
  },
  "AE": {
    "trial_1_ae": {
      "87": 0.27168717980384827,
      "173": 0.1841614991426468,
      "68": 0.17416898906230927,
      "78": 0.17416830360889435,
      "9": 0.16004344820976257,
      "123": 0.1524868905544281,
      "14": 0.14528067409992218,
      "49": 0.13771584630012512,
      "37": 0.12447796761989594,
      "177": 0.12430068850517273,
      "21": 0.12404019385576248,
      "67": 0.11722252517938614,
      "17": 0.1142372190952301,
      "189": 0.10971427708864212,
      "64": 0.1094050407409668,
      "20": 0.10892602056264877,
      "46": 0.10820793360471725,
      "77": 0.10205193608999252,
      "188": 0.10185525566339493,
      "76": 0.0938812717795372,
      "126": 0.09313135594129562,
      "2": 0.09215109050273895,
      "200": 0.08493304997682571,
      "396": 0.0848359540104866,
      "30": 0.08233963698148727,
      "61": 0.08199682086706161,
      "228": 0.0818152204155922,
      "79": 0.07885352522134781,
      "204": 0.07881379872560501,
      "101": 0.07738374173641205,
      "5": 0.07728568464517593,
      "131": 0.07356611639261246,
      "114": 0.07298677414655685,
      "350": 0.07259867340326309,
      "243": 0.07212300598621368,
      "147": 0.07091765105724335,
      "441": 0.06839166581630707,
      "104": 0.0651690885424614,
      "276": 0.0651569589972496,
      "116": 0.06234615296125412,
      "72": 0.06166914477944374,
      "18": 0.061021607369184494,
      "151": 0.059762656688690186,
      "28": 0.05944037437438965,
      "82": 0.05869098752737045,
      "193": 0.056205783039331436,
      "29": 0.05509058013558388,
      "85": 0.05434698611497879,
      "139": 0.05260855332016945,
      "138": 0.05259281024336815,
      "269": 0.05187640339136124,
      "239": 0.05141761526465416,
      "180": 0.049881815910339355,
      "261": 0.04976964741945267,
      "69": 0.04957497864961624,
      "96": 0.04930940642952919,
      "86": 0.048911433666944504,
      "361": 0.0488886795938015,
      "186": 0.048364996910095215,
      "211": 0.04786473512649536,
      "27": 0.047280460596084595,
      "286": 0.04558790475130081,
      "75": 0.044097818434238434,
      "38": 0.0426744744181633,
      "194": 0.04251861944794655,
      "33": 0.04134635627269745,
      "191": 0.04129514470696449,
      "747": 0.04124217852950096,
      "142": 0.04072888568043709,
      "466": 0.040716107934713364,
      "356": 0.04022279754281044,
      "97": 0.04019312933087349,
      "253": 0.04015727341175079,
      "164": 0.03937552124261856,
      "11": 0.038600854575634,
      "118": 0.03719301521778107,
      "25": 0.036436449736356735,
      "144": 0.03642823174595833,
      "454": 0.03639054298400879,
      "92": 0.0363803431391716,
      "221": 0.036160871386528015,
      "15": 0.035832080990076065,
      "179": 0.035769976675510406,
      "35": 0.03501658886671066,
      "422": 0.03423512354493141,
      "31": 0.03402155265212059,
      "130": 0.03385419398546219,
      "102": 0.0337260477244854,
      "355": 0.03362620994448662,
      "24": 0.033418308943510056,
      "132": 0.03323882445693016,
      "508": 0.03316105902194977,
      "456": 0.03286886587738991,
      "394": 0.03229469433426857,
      "297": 0.03217717632651329,
      "288": 0.031843021512031555,
      "282": 0.031807221472263336,
      "94": 0.0315156988799572,
      "234": 0.031503383070230484,
      "4": 0.031457073986530304
    },
    "trial_2_ae": {
      "87": 0.27168717980384827,
      "173": 0.1841614991426468,
      "68": 0.17416898906230927,
      "78": 0.17416830360889435,
      "9": 0.16004344820976257,
      "123": 0.1524868905544281,
      "14": 0.14528067409992218,
      "49": 0.13771584630012512,
      "37": 0.12447796761989594,
      "177": 0.12430068850517273,
      "21": 0.12404019385576248,
      "67": 0.11722252517938614,
      "17": 0.1142372190952301,
      "189": 0.10971427708864212,
      "64": 0.1094050407409668,
      "20": 0.10892602056264877,
      "46": 0.10820793360471725,
      "77": 0.10205193608999252,
      "188": 0.10185525566339493,
      "76": 0.0938812717795372,
      "126": 0.09313135594129562,
      "2": 0.09215109050273895,
      "200": 0.08493304997682571,
      "396": 0.0848359540104866,
      "30": 0.08233963698148727,
      "61": 0.08199682086706161,
      "228": 0.0818152204155922,
      "79": 0.07885352522134781,
      "204": 0.07881379872560501,
      "101": 0.07738374173641205,
      "5": 0.07728568464517593,
      "131": 0.07356611639261246,
      "114": 0.07298677414655685,
      "350": 0.07259867340326309,
      "243": 0.07212300598621368,
      "147": 0.07091765105724335,
      "441": 0.06839166581630707,
      "104": 0.0651690885424614,
      "276": 0.0651569589972496,
      "116": 0.06234615296125412,
      "72": 0.06166914477944374,
      "18": 0.061021607369184494,
      "151": 0.059762656688690186,
      "28": 0.05944037437438965,
      "82": 0.05869098752737045,
      "193": 0.056205783039331436,
      "29": 0.05509058013558388,
      "85": 0.05434698611497879,
      "139": 0.05260855332016945,
      "138": 0.05259281024336815,
      "269": 0.05187640339136124,
      "239": 0.05141761526465416,
      "180": 0.049881815910339355,
      "261": 0.04976964741945267,
      "69": 0.04957497864961624,
      "96": 0.04930940642952919,
      "86": 0.048911433666944504,
      "361": 0.0488886795938015,
      "186": 0.048364996910095215,
      "211": 0.04786473512649536,
      "27": 0.047280460596084595,
      "286": 0.04558790475130081,
      "75": 0.044097818434238434,
      "38": 0.0426744744181633,
      "194": 0.04251861944794655,
      "33": 0.04134635627269745,
      "191": 0.04129514470696449,
      "747": 0.04124217852950096,
      "142": 0.04072888568043709,
      "466": 0.040716107934713364,
      "356": 0.04022279754281044,
      "97": 0.04019312933087349,
      "253": 0.04015727341175079,
      "164": 0.03937552124261856,
      "11": 0.038600854575634,
      "118": 0.03719301521778107,
      "25": 0.036436449736356735,
      "144": 0.03642823174595833,
      "454": 0.03639054298400879,
      "92": 0.0363803431391716,
      "221": 0.036160871386528015,
      "15": 0.035832080990076065,
      "179": 0.035769976675510406,
      "35": 0.03501658886671066,
      "422": 0.03423512354493141,
      "31": 0.03402155265212059,
      "130": 0.03385419398546219,
      "102": 0.0337260477244854,
      "355": 0.03362620994448662,
      "24": 0.033418308943510056,
      "132": 0.03323882445693016,
      "508": 0.03316105902194977,
      "456": 0.03286886587738991,
      "394": 0.03229469433426857,
      "297": 0.03217717632651329,
      "288": 0.031843021512031555,
      "282": 0.031807221472263336,
      "94": 0.0315156988799572,
      "234": 0.031503383070230484,
      "4": 0.031457073986530304
    }
  },
  "safety": {
    "trial_1_safety": 0.32466328144073486,
    "trial_2_safety": 0.32466328144073486
  },
  "efficacy": {
    "prob_trial1_gt_trial2": 0.4755811095237732
  }
}